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Universidade Federal de Sa˜o Paulo, Sa˜o Paulo, BrazilABSTRACT The raft hypothesis proposes that microdomains enriched in sphingolipids, cholesterol, and specific proteins are
transiently formed to accomplish important cellular tasks. Equivocally, detergent-resistant membranes were initially assumed to
be identical to membrane rafts, because of similarities between their compositions. In fact, the impact of detergents in membrane
organization is still controversial. Here, we use phase contrast and fluorescence microscopy to observe giant unilamellar
vesicles (GUVs) made of erythrocyte membrane lipids (erythro-GUVs) when exposed to the detergent Triton X-100 (TX-
100). We clearly show that TX-100 has a restructuring action on biomembranes. Contact with TX-100 readily induces domain
formation on the previously homogeneous membrane of erythro-GUVs at physiological and room temperatures. The shape and
dynamics of the formed domains point to liquid-ordered/liquid-disordered (Lo/Ld) phase separation, typically found in raft-like
ternary lipid mixtures. The Ld domains are then separated from the original vesicle and completely solubilized by TX-100.
The insoluble vesicle left, in the Lo phase, represents around 2/3 of the original vesicle surface at room temperature and
decreases to almost 1/2 at physiological temperature. This chain of events could be entirely reproduced with biomimetic
GUVs of a simple ternary lipid mixture, 2:1:2 POPC/SM/chol (phosphatidylcholine/sphyngomyelin/cholesterol), showing that
this behavior will arise because of fundamental physicochemical properties of simple lipid mixtures. This work provides direct
visualization of TX-100-induced domain formation followed by selective (Ld phase) solubilization in a model system with a
complex biological lipid composition.INTRODUCTIONBiological membranes are complex and dynamic systems
responsible for a variety of cellular activities such as
compartmentalization, communication, transport, and en-
ergy conversion (1). The raft hypothesis (2) postulates that
functional domains rich in sphingolipids, cholesterol, and
certain classes of proteins are momentarily assembled to
perform crucial roles in several essential cellular processes,
such as endocytosis and cell signaling (2,3). The existence of
rafts is still controversial, but a large body of evidence gives
support to their existence and physiological role (4–9). The
importance of the lipid composition in biological mem-
branes became evident from studies in model membranes
composed of mimetic lipid mixtures. In a certain composi-
tion and temperature range, simple ternary lipid mixtures
of unsaturated, long saturated lipids, and cholesterol exhibit
macroscopic phase separation between a liquid-disordered
(Ld) phase—rich in unsaturated lipids—and a liquid-ordered
(Lo) phase—rich in saturated lipids and cholesterol (10). In
particular, observation of giant unilamellar vesicles (GUVs)
has proven to be a key approach in determining lateral phase
separation in model membranes of different lipid composi-
tions (10–12) and in cellular extracts (6,13,14).
Given the variety and complexity of the composition of
biological membranes, a convenient way to separate mem-
brane components and study them individually is via proto-Submitted March 6, 2014, and accepted for publication April 29, 2014.
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0006-3495/14/06/2417/9 $2.00cols of membrane solubilization with detergents. Such
procedure often leaves insoluble fractions, the so-called
detergent-resistant membranes (DRMs) (2), which are
also rich in raft-like components (15,16). Thus, DRMs
were initially assumed to be identical to membrane rafts
(17,18). However, DRMs were shown to be highly deter-
gent- and protocol-dependent (15,16,19) and detergent
insertion into the membrane can certainly alter and reshape
the membrane and lead to nonphysiological conditions
(20–22). Detergent extraction of membrane constituents is
often performed via standard protocols in which the effect
of the detergent on membrane structure is not followed dur-
ing the solubilization process. Therefore, a deeper under-
standing of the effects of detergents on biological
membranes is still lacking and can certainly help unravel
the complex architecture of biological membranes.
The nonionic detergent Triton X-100 (TX-100) has been
widely used in protocols of membrane solubilization and
extraction of DRMs (21,23). Therefore, various studies
have addressed the TX-100-induced solubilization of
biological membranes (24,25) as well as of model mem-
branes of diverse composition and in different phases
(26–29). The ability of TX-100 to interact and solubilize
membranes is strongly modulated by the lipid phase and
composition (27,30,31). It has been reported that TX-100
induces Lo/Ld phase separation in model membranes with
preferential solubilization of the Ld phase (20,32,33). How-
ever, visualization of these effects induced by TX-100 on
model systems was achieved only with atomic forcehttp://dx.doi.org/10.1016/j.bpj.2014.04.039
2418 Casadei et al.microscopy (AFM) of supported lipid bilayers (32,33),
which might be influenced by the solid support. Rearrange-
ment of membrane components induced by TX-100 was
also observed in biological membranes (21,34). Similarly,
unsaturated lipids are preferentially solubilized from biolog-
ical membranes (21), and TX-100 DRMs were shown to be
enriched in sphingolipids and cholesterol (35). Yet, it has
been claimed that TX-100 might rather induce coalescence
of preexisting nanodomains than formation of new domains
from a homogeneous mixture (36).
Here, we use optical microscopy to directly observe the
effects of TX-100 on a model system closer to a biological
membrane: GUVs made of erythrocyte membrane lipid
extract. Erythrocyte plasma membranes have been
described in great detail (37) and they are suitable for the
study of biological membranes because erythrocytes contain
no organelles, making the isolation of their plasma mem-
brane quite simple. In addition, the alterations caused by
detergents in dynamic and structural properties of erythro-
cyte membranes can be monitored by different approaches
(8,25,38), making this complex biomembrane a suitable
model to explore the effect of detergents on membrane orga-
nization. Although GUVs of erythrocyte lipids are still a
simplified model of erythrocyte membranes, because pro-
teins are absent and lipid asymmetry is lost, they preserve
the complex lipid composition and can reveal lipid-depen-
dent behavior of erythrocytes in a controlled situation. For
comparison, GUVs made of the biomimetic ternary compo-
sition palmitoyl oleoyl phosphatidylcholine (POPC), egg
sphingomyelin (SM), and cholesterol are also investigated.
Previously, the solubilization process of POPC by TX-100
has revealed that TX-100 initially inserts into the bilayer,
causing a considerable increase in vesicle surface area, fol-
lowed by opening of holes and complete solubilization (28).
Here, we show that TX-100 first induces Lo/Ld phase sepa-
ration followed by solubilization of the Ld phase only. Inter-
estingly, the Ld domains that were first separated from the
insoluble Lo vesicle, could even form separated vesicles,
and were only then completely solubilized by TX-100.
The fraction of insoluble vesicle surface area is quantified
at room and physiological temperatures and a composition
for the insoluble membrane is proposed. The behavior
obtained for GUVs made of erythrocyte lipids could be
well reproduced with a simple ternary lipid mixture,
showing that this is a universal effect of TX-100 on lipid
membranes. Our results are relevant in the context of mem-
brane organization and show that detergents can be potent
membrane reshaping agents.MATERIALS AND METHODS
Materials
The phospholipids POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line), sphingomyelin (egg, chicken), cholesterol, and the fluorescent probeBiophysical Journal 106(11) 2417–2425Rh-DPPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-lissamine
rhodamine B sulfonyl) were purchased from Avanti Polar Lipids (Birming-
ham, AL). Triton X-100 was from Sigma-Aldrich (St. Louis, MO). All other
chemicals used were of analytical grade.Lipid extraction from erythrocyte ghosts
Fresh human blood from healthy donors was obtained from a blood bank
(approved by the Ethics in Research Committee, FCM/Unicamp, # 227/
2009 protocol). Erythrocytes were isolated by centrifugation at 1000  g
for 5 min followed by three washes in phosphate-buffered saline (PBS,
5 mMNa-phosphate, 154.5 mM NaCl, 4.5 mM KCl, pH 7.4). After dilution
of the erythrocytes in PBS (1:1, v:v), the suspension was then filtered
through a-cellulose/microcrystalline cellulose to isolate erythrocytes
from platelets and leukocytes (39). The purified erythrocyte suspension
was then washed three times in PBS, and the packed cells were used to
isolate plasma membrane (ghosts). Ghost membranes were prepared as
previously described by Dodge and co-workers (40), with minor modifica-
tions (19). Briefly, one volume of packed erythrocyte cells was lysed in nine
volumes of hypotonic phosphate buffer. After centrifugation, the superna-
tant was carefully removed and cell membranes were washed with the
same buffer until white ghosts (hemoglobin-free) were obtained. Finally,
the ghost membranes were washed (three times) and kept in TN buffer
(25 mM Tris/HCl, 150 mM NaCl, pH 7.4). Lipid extraction from ghost
membranes was performed with chloroform, methanol, and water (2:1:1,
v:v:v), according to Folch’s method (41). The organic phase obtained after
extraction was concentrated in chloroform and phospholipids were quanti-
fied by analysis of inorganic phosphorus (42).Preparation of GUVs
GUVs made of lipids extracted from erythrocyte ghosts and mixtures of
POPC/SM/Cholesterol (2:1:2, 1:1:2 or 0.8:1:2) were grown using the
electroformation method (43). Few microliters of a 2.5 mM lipid chloro-
form solution, with or without the fluorescent dye Rh-DPPE (1 mol % of
the total lipids), were spread on the surfaces of two conductive glasses
coated with fluorine tin oxide. After drying of the lipid film in a stream
of N2, the glasses were mounted to form a chamber with a 2 mm thick
Teflon frame. This chamber was filled with 0.2 M sucrose solution, placed
in an incubator at 50C, and the glass slides were connected to a function
generator that applied an alternating current of 1 V with a 10 Hz frequency.
After 1 h, the GUVs formed were removed from the electroformation
chamber and diluted ~10–20 in an equiosmolar glucose solution. The
sugar asymmetry created enhanced the optical contrast of the GUVs
when observed in phase contrast mode and stabilized the vesicles on the
bottom of the observation chamber.Imaging of GUVs
GUVs were observed either in phase contrast or in fluorescent mode with an
inverted microscope Zeiss Axiovert 200 (Jena, Germany) equipped with a
Zeiss AxioCamHSm digital camera and a 63 Ph2 objective. Fluorescence
imaging was achieved with illumination from a mercury lamp HBO 103W
and a set of filters with excitation at 540–552 nm and emission band at
575640 nm. Two different experimental setups were used to observe
the solubilization of GUVs by the detergent TX-100. In the first one, a
0.2 M glucose solution containing 5 mM TX-100 was injected with a glass
micropipette of ~10 mm diameter placed close to a chosen GUV. The micro-
pipettes were prepared using a vertical puller PC-10 from Narishige (Tokyo,
Japan) and were controlled with a micromanipulator MP-225 from Sutter
Instruments (Novato, CA). The injection flux was adjusted manually with
a micrometer knob pressing a 10 mL Hamilton syringe (Sutter Instruments).
In the second experimental setup, 5 mL of a suspension of GUVs prepared
Action of Triton X-100 on Erythro-GUVs 2419in 0.2 M sucrose were diluted in 95 mL of a 0.2 M glucose solution (lipid
concentration around 1 mM) containing increasing concentrations of TX-
100 and then immediately placed in a homemade observation chamber.
The experiments were performed either at room temperature (~22–25C)
or in an observation chamber connected to a water circulating bath to
perform experiments at 37C (the temperature was measured with a thermo-
couple placed inside the observation chamber).RESULTS
The solubilization process of GUVs from erythrocyte
membrane lipids (termed here as erythro-GUVs) by the
detergent TX-100 was observed with phase contrast and
fluorescence microscopy. A solution of 5 mM TX-100 was
injected with a micropipette placed close to the selected
erythro-GUVs. After contact with the detergent solution,
all erythro-GUVs observed were partially solubilized, as
detected by a clear decrease in vesicle size. In some cases,
it was possible to clearly distinguish that part of the vesicle
was first detached from the original vesicle and then
completely solubilized. Fig. 1 A shows one such example
observed under phase contrast microscopy. After 30 s of
TX-100 injection, part of the erythro-GUV is detached
and then solubilized in a few seconds. The last snapshot
(40 s) shows the insoluble fraction of the erythro-GUV,
which is clearly smaller than the original vesicle and has
lost the initial sugar asymmetry responsible for the high
optical contrast seen in the first snapshot. Further injection
of TX-100 has no effects on the insoluble fraction. A movie
of another erythro-GUV during injection of TX-100 is
shown in the Supporting Material (Movie S1 A).
The solubilization process was also imaged with fluores-
cence microscopy. One selected representative sequence is
shown in Fig. 1 B. Before contact with TX-100, all
erythro-GUVs show a homogeneous distribution of the
fluorescent probe used, Rh-DPPE, attesting that the lipid
extract of the erythrocyte membrane did not exhibit detect-
able phase separation (see snapshots at 0 and 22 s in
Fig. 1 B). The first effect caused by TX-100 was the ready
formation of circular domains enriched in the fluorescentFIGURE 1 Time sequences obtained during injection of a 5 mM TX-100 solu
Phase contrast microscopy mode, (B) fluorescence microscopy mode of eryth
moment when the vesicles were placed in front of the injection flux, which cam
performed at room temperature. Video sequences can be seen in Movie S1, A aprobe (as easily seen in Fig. 1 B, snapshots 39–110 s).
The formed domains diffused on the vesicle surface,
coalesced, and eventually the two phases were completely
separated (110 s). The fact that the domains are round,
diffuse, and coalesce show that both phases are liquid, i.e.,
Ld and Lo (44). In fact, the shape and dynamics of the
domains formed in the presence of TX-100 resemble those
seen in GUVs composed of classic ternary raft-like lipid
mixtures, such as unsaturated PC, SM, and cholesterol,
which display Lo/Ld phase separation in a certain composi-
tion and temperature range (11,12,44,45). The fluorescent
probe used here is known to preferentially partition into
the Ld phase (12,46). A control experiment showing this
preferential partitioning of Rh-DPPE in the Ld phase was
performed (see Fig. S1). Furthermore, to prove that the
domains are fluid and the matrix is in the Lo phase, confocal
microscopy images were obtained from erythro-GUVs
containing the fluorescent probe Laurdan, whose emission
wavelength is sensitive to the bilayer order (44) (see
Fig. S2). It can be concluded that TX-100 induces the for-
mation of detectable Lo/Ld phase separation in erythro-
GUVs, in a manner similar to the commonly investigated
raft-like mimetic compositions. After domain formation,
the fluid part of the erythro-GUV is solubilized and the
remaining insoluble vesicle—in the Lo phase—exhibits
only a faint fluorescence (142 s). The complete movie of
Fig. 1 B is shown in Movie S1 B.
The experimental design of injection with a micropipette
has the drawback that the concentration of TX-100 close to
the vesicle surface is not well defined, and depends on the
flux condition. Therefore, a different experimental setup
was also used. A small aliquot of a suspension of erythro-
GUVs was added to a solution of TX-100 of known concen-
tration, previously prepared in the observation chamber. In
this setup, the vesicles in the absence of TX-100 could not
be imaged. However, the effects of TX-100 at a fixed
concentration could be determined. Overall, the same
behavior observed with the injection protocol of a con-
centrated TX-100 solution was observed when thetion in 0.2 M glucose with a glass micropipette close to erythro-GUVs. (A)
ro-GUVs containing 1 mol % Rh-DPPE. The indicated times refer to the
e from the right side. The scale bars represent 10 mm. Experiments were
nd B.
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above its critical micelle concentration (cmc ¼ 0.27 mM
for the conditions explored here (28)). Fig. 2 shows time
sequences obtained for erythro-GUVs when added to TX-
100 at increasing (0.2–0.4 mM) concentrations. The
complete movies of the sequences shown in Fig. 2 are
shown in Movie S2, A, B, and C. When exposed to
0.2 mM TX-100, most of the erythro-GUVs displayed phase
separation after a few seconds. Fig. 2 A shows that formation
and coalescence of domains induced by 0.2 mM TX-100
took place within a few minutes in one erythro-GUV. In
the first seconds, the vesicle surface shows a homogeneous
distribution of the fluorescent probe; after 30 s Lo/Ld phase
separation is promoted and the domains coalesce with time.
Even after longer periods of observation (up to 10 min), only
vesicles with domains were observed, but no partial solubi-
lization. When added to 0.3 mM TX-100, thus close to the
cmc of TX-100, erythro-GUVs initially show the formation
and coalescence of domains within the first seconds,
followed by detachment of fluid domains, as shown in
Fig. 2 B (145–205 s). Apparently, each Ld patch removed
reseals into one vesicle. Some of these fluid vesicles are
then solubilized and the original vesicle is left with a very
faint fluorescence (205 s). Addition of erythro-GUVs to
0.4 mM TX-100 causes almost immediate formation and
coalescence of domains with further detachment and solubi-
lization of the fluid part, as shown in Fig. 2 C. Again, each
detached domain forms one vesicle that is later solubilized.FIGURE 2 Time sequences obtained with fluorescence microscopy after addit
sion into different concentrations of TX-100, as indicated. The indicated times re
Scale bars represent 20 mm (A) and 10 mm (B and C). Experiments were perform
and C.
Biophysical Journal 106(11) 2417–2425After a few minutes, only the insoluble Lo fraction is
observed (see last snapshot in Fig. 2 C). In the presence
of higher TX-100 the effects observed are mainly the
same as those with 0.4 mM TX-100, but the whole process
occurs faster. Therefore, the onset of the partial solubili-
zation occurs around the cmc of TX-100, in accordance
with previous results on the solubilization of GUVs
composed of POPC (28). At low concentrations of TX-
100 (Fig. 2 A), only Lo/Ld phase separation is promoted.
Remarkably, no change in vesicle size was observed in
this initial stage, contrary to the clear increase in the size
of GUVs composed of POPC (28), indicating that the inser-
tion of TX-100 into the erythro-GUVs membrane is less
favored than in fluid POPC vesicles.
The lipid extract of erythrocyte membranes comprise
several lipid types with a well-known composition (47). In
an attempt to model such a complex system, a predeter-
mined ternary mixture of lipids was also investigated. Based
on typical values of the relative fraction of such lipids in
erythrocyte membranes (47), the ternary lipid composition
2:1:2 POPC/SM/chol (molar ratio) was chosen. GUVs of
this biomimetic composition were grown and their solubili-
zation by TX-100 was tracked with optical microscopy.
Interestingly, the solubilization process of biomimetic
GUVs followed the same sequence of events described
previously for erythro-GUVs. One example is shown in
Fig. 3 A. The biomimetic GUV is initially homogeneously
fluorescent (0 s), showing that no detectable phaseion of small aliquots of an erythro-GUVs (with 1 mol % Rh-DPPE) suspen-
fer to the moment of erythro-GUVs addition to a given TX-100 preparation.
ed at room temperature. The video sequences are shown in Movie S2, A, B,
FIGURE 3 Time sequences obtained during injection of a 5 mMTX-100 solution in 0.2 M glucose with a glass micropipette. (A) Fluorescence microscopy
of a GUV composed of 2:1:2 POPC/SM/chol at room temperature. The brightness of the last snapshot (160 s) was increased to help visualization of the
insoluble vesicle fraction, which is only faintly fluorescent. (B) Fluorescence microscopy sequence of an erythro-GUV at 37C. The brightness of the
last snapshot (100 s) was increased to help visualization of the insoluble vesicle fraction, which is only faintly fluorescent. (C) Fluorescence (0–47 s)
and phase contrast microscopy (55–73 s) sequence of a GUV composed of 2:1:2 POPC/SM/chol at 37C. The indicated times on each sequence refer to
the moment when the vesicles were placed in front of the injection flux, which came from the right side. The scale bars represent (A) 20 mm and
(B and C) 10 mm. All GUVs contained 1 mol % Rh-DPPE. The respective video sequences are shown in Movie S3, A, B, and C.
Action of Triton X-100 on Erythro-GUVs 2421separation is observed for this composition at room temper-
ature. Contact with TX-100 readily promotes phase separa-
tion and domain coalescence (8–72 s). Because the injection
flux comes from the right side, domains form initially on the
vesicle side facing the flux, and then migrate along the
vesicle surface until the Ld domain separates from the orig-
inal vesicle (98 s) giving rise to an individual vesicle (136 s),
which is then completely solubilized (160 s). The insoluble
fraction that remains after 160 s is in the Lo phase, is clearly
smaller than the initial vesicle, and only faintly fluorescent.
The complete video of Fig. 3 A can be seen in Movie S3 A.
The experiments reported here were performed at room
temperature. The composition of DRMs was found to be
sensitive to the temperature (48), but solubilization proto-
cols to yield DRMs are generally performed at 4C
(15,49,50). So far, only a few studies have been conducted
at physiological temperature, especially for erythrocytes
(16). Here, we explore the effect of increasing the tempera-
ture to physiological condition, 37C. It would be certainly
interesting to test 4C as well, but water condensation on the
chamber glass hinders optical observation below ~18C.
Basically, the same chain of events reported before at
room temperature (Figs. 1 and 2) are observed for both
erythro-GUVs and biomimetic GUVs at physiological
temperature: the initially homogeneous membrane exhibitphase separation after contact with TX-100 and the fluid
domains are detached from the original vesicle and
completely solubilized. Fig. 3, B and C, show one typical
erythro-GUV and one biomimetic GUV at 37C during
injection of 5 mM TX-100. The video sequences can be
seen in Movie S3, B and C). It is important to stress that
also at physiological temperature, erythrocyte membrane
lipids and its biomimetic composition are apparently
homogenous but display phase separation triggered by the
presence of TX-100. The fluid fraction for both erythro-
GUVs and biomimetic composition, and therefore the
solubilized portion later, is clearly larger than at room
temperature (compare snapshots at 55 s in Fig. 3, B and
C, with snapshots at room temperature, 93 s in Fig. 3 A).
This was expected, as membrane fluidity should increase
with temperature, especially if the melting temperature of
sphingomyelins, around 40C, is approached.
After contact with TX-100, both erythro-GUVs and
biomimetic GUVs were partially solubilized, leaving a
smaller insoluble spherical vesicle. The fraction of the
original vesicle surface insoluble to TX-100 can be easily
calculated as Xinsoluble ¼ (Dafter/Dbefore)2, where Dbefore
and Dafter are the vesicle diameters before and after contact
with TX-100, respectively. The Xinsoluble values obtained for
erythro-GUVs and biomimetic GUVs at both room andBiophysical Journal 106(11) 2417–2425
2422 Casadei et al.physiological temperatures are shown in Fig. 4 A. The
Xinsoluble values obtained for erythro-GUVs at each temper-
ature could be very well reproduced with the biomimetic
composition. At room temperature, Xinsoluble for both com-
positions is around 0.68 5 0.10, and this value decreases
to around 0.54 5 0.10 when the temperature is increased
to 37C. The considerably high data scatter for each
membrane composition and temperature can be explained
from the known variance of lipid composition within a batch
of GUVs.
Based on previous and our observations (20,32,33), TX-
100 selectively solubilizes the Ld phase only, leaving the
Lo phase intact. Therefore, in a first approximation, we
can assume that only POPC is solubilized from the biomi-
metic mixture (POPC/SM/chol) at room temperature, which
is supported by previous data (32,33). This assumption
might not hold for 37C, because of the proximity withFIGURE 4 Fraction of vesicle surface area insoluble after treatment with
TX-100, obtained from Xinsoluble¼ (Dafter/Dbefore)2, where Dbefore and Dafter
are the diameters of the vesicles before and after contact with TX-100,
respectively. Only spherical vesicles were considered. (A) Temperature
dependence of Xinsoluble of erythro-GUVs (N ¼ 120 at room temperature
and 51 at 37C) and 2:1:2 POPC/SM/chol GUVs (N¼ 115 at room temper-
ature and 20 at 37C). (B) Dependence of Xinsoluble on membrane composi-
tion (indicated in the x axis). N¼ 25 (1:1:2 POPC/SM/chol) and 20 (1:1:0.8
POPC/SM/chol). To see this figure in color, go online.
Biophysical Journal 106(11) 2417–2425the melting temperature of SM. For 2:1:2 POPC/SM/chol
GUVs at room temperature, around 1/3 of the vesicle sur-
face is solubilized and 2/3 remain insoluble. Because the
area per lipids in different conditions is known from previ-
ous studies, it is possible to propose a lipid composition for
the insoluble fraction of this biomimetic system. The
following areas per lipids were assumed here (51–53):
63 A˚2 for POPC in the presence of 40 mol % cholesterol
(before contact with TX-100) or 70 A˚2 in the Ld phase (after
contact with TX-100); 55 A˚2 for SM in the homogenous
phase (before contact with TX-100) or 51 A˚2 in the Lo phase
(after contact with TX-100); 27 A˚2 for cholesterol. Based on
these values and our data, the proposed composition of the
insoluble fraction at room temperature is 0.8:1:2 POPC/
SM/chol, i.e., solubilization of 60% of the POPC lipids.
To test this hypothesis, GUVs of that composition were
grown and exposed to injection of 5 mM TX-100 with a
micropipette. In fact, these GUVs were insensitive to the
presence of TX-100, and no effects whatsoever were
observed (domain formation, partial solubilization, or
contrast loss). To further test the dependence of Xinsoluble
on membrane composition, another composition, close to
this completely insoluble one, was also probed, namely
1:1:2 POPC/SM/chol. The insoluble fraction measured for
various GUVs at this composition was Xinsoluble ¼ 0.91 5
0.07, i.e.; between the values obtained for 2:1:2 and
0.8:1:2, as expected. Furthermore, if the same solubilization
reasoning is applied for the 1:1:2 mixture, the expected
composition of the insoluble fraction should also be
0.8:1:2, again validating this composition as virtually insol-
uble and representative of DRMs obtained at room temper-
ature. The dependence of Xinsoluble with the membrane
composition obtained at room temperature is shown in
Fig. 4 B. Clearly, Xinsoluble increases as the relative fraction
of POPC in the mixtures decreases. It would be interesting
to relate the composition of the fully resistant vesicles
with the composition of domains in phase separated mem-
branes, as defined by the tie lines in the phase diagram of
this system. Unfortunately, to the best of our knowledge,
the phase diagram of the mixture POPC/SM/chol has not
been reported, and only a few tie lines for a similar mixture
have been reported so far (54).DISCUSSION
The effects caused by TX-100 on GUVs composed of
biomimetic systems of erythrocytes were observed with
optical microscopy. On the one hand, the lipid extract of
erythrocyte ghosts were used to grow erythro-GUVs, which
retained the complexity in lipid composition of the original
cells. On the other hand, a quite simple and commonly used
biomimetic system was also investigated, namely 2:1:2
POPC/SM/chol. Interestingly, this simple ternary mixture
could well mimic the complex biological composition of
erythro-GUVs, showing that the phenomena promoted by
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icochemical properties characteristic for simple ternary
lipid mixtures. Both at room and physiological tempera-
tures, TX-100 readily induced macroscopic Lo/Ld phase
separation with further solubilization of only the fluid
part, leaving insoluble a smaller vesicle in the Lo phase.
The Lo insoluble fraction decreased from ~2/3 of the vesicle
surface at room temperature to almost 1/2 at 37C. Further-
more, we showed that the insoluble fraction at room temper-
ature increases when the relative amount of POPC in the
mixture is decreased, up to the point when a virtually in-
soluble composition, namely 0.8:1:2 POPC/SM/chol, is
obtained. Our data show that both membrane composition
and temperature are crucial factors determining phase sepa-
ration and the fraction of insoluble membrane. Additionally,
the influence of membrane proteins in detergent resistance is
likely to also play a key role, which deserves to be further
investigated in future works.
The findings reported here correlate well with previous
studies from the literature. Calorimetric studies on 1:1:1
POPC/SM/chol show that TX-100 induces domain forma-
tion, probably because of the preferential partitioning of
TX-100 into fluid bilayers, therefore segregating Lo patches,
enriched in SM/chol (20,55). Supported lipid bilayers of
ternary mixtures of DOPC/SM/chol, which exhibit Lo/Ld
phase separation were imaged with AFM in the presence
of TX-100 (32,33). Both studies show that TX-100 selec-
tively solubilizes the Ld phase only, leaving the Lo domains
essentially unaltered. Furthermore, Garner and co-workers
(33) showed that TX-100 promotes phase separation in
mixtures that were initially homogeneous. The same effect
was shown in GUVs of DOPC/DPPC/chol in the presence
of TX-100 (22). Our data show the same phenomena, with
the benefit that GUVs offer a better picture of the cell
membrane as compared to supported bilayers and that
more complex biological lipid mixtures were also investi-
gated. Furthermore, our observations reveal an interesting
mechanistic aspect of the partial solubilization: The fluid
domains are first removed from the insoluble vesicle, even
forming separate vesicles if the process is done slow
enough, and are only then finally solubilized by TX-100.
Interestingly, TX-100 also promoted similar effects on the
plasma membrane of COS cells (a fibroblast-like cell line)
(21). TX-100 induces a profound remodeling of the plasma
membrane, with the formation of highly condensed domains
enriched in cholesterol and a preferential solubilization of
the fluid regions of the plasma membrane. However, these
observations were done at 4C, whereas ours were per-
formed at both room and physiological temperatures. More-
over, TX-100 was shown to induce clustering of PIP2 in the
membrane of HEK293 cells (34). The existence of an insol-
uble fraction after treatment of erythro-GUVs with TX-100
at both low and physiological temperature is in very good
agreement with our previous data for DRMs from intact
erythrocytes (16). Additionally, not only the lipid composi-tion of the insoluble membrane fraction might be affected
by the temperature, as described here, but also raft marker
proteins are more solubilized at 37C (16).
Another study proposes that TX-100 actually promotes
coalescence of preexisting nanodomains rather than forma-
tion of new domains in model membranes composed of
1:1:1 POPC/SM/chol (36). Given our optical resolution
(~0.3 mm) we cannot discard this hypothesis. AFM images,
which offer a better spatial resolution, show that the compo-
sition that exhibited domain formation after contact with
TX-100 was initially homogenous within <100 nm (33).
Recent studies show that domain size is modulated by thick-
ness mismatch between the Ld and Lo phases: whereas only
nanoscopic domains are detected in ternary mixtures
containing only POPC, domain size increases as POPC is
gradually replaced in the mixture by DOPC (56). Therefore,
TX-100 could induce macroscopic domain formation by
preferentially partitioning into the fluid phase and inducing
membrane thinning of this phase. Additionally, calorimetric
studies propose that potential preexisting domains in 1:1:1
POPC/SM/chol membranes are only marginally stable and
highly responsive to small perturbations (20,55). Therefore,
we can hypothesize that such ternary mixtures have the
potential to exhibit phase separation as a response to
different stimuli. Furthermore, experiments performed on
giant plasma membrane vesicles have revealed that even
in a one-phase region, micrometer-scale composition fluctu-
ations occurred, showing that the compositions of biological
membranes might be tuned to reside near miscibility critical
points (6,57). In living cells, which are highly dynamic
complex systems not in equilibrium, several aspects of the
cell membrane would prevent the development of macro-
scopic phase separation, such as presence of membrane-
associated proteins, constraining of the membrane surface
by the underlying cytoskeleton, and active transport and
signaling (6,57). On the other hand, the basic constituents
for lipid-driven segregation are present in biological mem-
branes, and given the right stimuli, functional raft domains
might form transiently, accomplish their function, and disas-
semble eventually. Furthermore, different stimuli might
trigger the formation of rafts with variable composition,
which might be important to allow the cell to perform
distinct tasks according to the momentary requirements. It
seems clear that detergents, such as TX-100, are noticeable
candidates to promote such perturbation and are able to
reshape both model and cell membranes. Therefore, the
composition of DRMs could be influenced by the extraction
protocol used. Even though our results suggest that DRMs
do not represent preexisting microdomains, the use of
DRMs is still useful for separation of membrane con-
stituents and might help predict the preference of specific
proteins to raft-like environment. However, we stress the
importance of defining the effects caused by the detergent
used in each specific extraction condition explored, because
detergents such as TX-100 might affect the lateralBiophysical Journal 106(11) 2417–2425
2424 Casadei et al.distribution of both lipids and proteins. Other detergents,
such as C12E8, also widely used in biochemical studies,
have also shown preferential solubilization of the Ld phase
(27) and particularly, C12E8 DRMs from erythrocytes
exhibited Lo-like phase as well as TX-100 DRMs (16,19).
The resistance of biomembranes to other detergents is
currently under investigation in our laboratory.
In summary, our experiments provide a direct visuali-
zation of the action of TX-100 on GUVs of a complex bio-
logical lipid composition. TX-100 undoubtedly induces
macroscopic domain formation in erythro-GUVs, with a
sequence of events that was found to be reproducible in a
simple ternary lipid mixture (2:1:2 POPC/SM/chol). How-
ever, whether or not TX-100 promotes the coalescence of
preexisting nanodomains remains an open question. After
phase separation, TX-100 selectively solubilizes the Ld
and leaves an insoluble (smaller) vesicle in the Lo phase.
Our results conclusively show that TX-100 has a profound
restructuring effect on the lateral organization of lipids in
model and complex biological membranes. Therefore,
detergent extraction protocols of membrane constituents
should be carefully evaluated for each system and DRMs
should not be directly associated with preexisting mem-
brane structures.SUPPORTING MATERIAL
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